A series of immunoassays have recently been elaborated in which the red cell is used as a label or marker of interacting antibody, often anti-immunoglobulin (anti-Ig). This paper considers and investigates quantifiably, the different variables which affect the sensitivity of direct and indirect antiglobulin rosetting reactions (DARR and IARR) and of reverse passive haemagglutination (RPH). Sensitivity is governed by the surface properties and amount of antibody on the indicator red cell and, in detection of cell-bound antigen, by the antigen density. By varying the antibody:Ig ratio on the red cell using affinity purified anti-Ig, cells with more than 1:32–64 antibody:Ig showed similar sensitivity in detection of lymphocyte sIg in DARR and IARR tests and of serum Ig by RPH. Using these indicator cells coupled with different Ab:Ig ratios to detect lymphocytes sensitized with different levels of anti-Ig in a model IARR test, it was clear that studying cells with a high density of determinants on the lymphocyte surface it is not necessary to have `strong' anti-immunoglobulin on the indicator cell, but increasingly sparse determinants require increasingly strong anti-Ig on the red cell to detect all positively reacting cells. Red cells of different species afford carriers of varing sensitivity in all three reactions—DARR, IARR and RPH. Preliminary trypsin treatment may greatly further enhance the sensitivity of some species red blood cells (e.g. bovine and sheep), but leaves others (e.g. pig and donkey) unchanged. Use of I-labelled Ig and anti-Ig showed that the increased sensitivity of trypsinized bovine and sheep RBC is not due to increased uptake of Ig during chromic chloride linkage or of antibody in agglutinations.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1555573 | PMC |
J Med Internet Res
January 2025
Department of Gastroenterology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Background: Gastrointestinal bleeding (GIB) is a severe and potentially life-threatening complication in patients with acute myocardial infarction (AMI), significantly affecting prognosis during hospitalization. Early identification of high-risk patients is essential to reduce complications, improve outcomes, and guide clinical decision-making.
Objective: This study aimed to develop and validate a machine learning (ML)-based model for predicting in-hospital GIB in patients with AMI, identify key risk factors, and evaluate the clinical applicability of the model for risk stratification and decision support.
Ocul Immunol Inflamm
January 2025
Universiti Malaya Eye Research Centre (UMERC), Department of Ophthalmology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
Purpose: To shed light on one of the ocular adverse effects related to pembrolizumab.
Method: Case report and literature review.
Result: A 53-year-old gentleman with underlying Stage III B renal cell carcinoma with lung metastasis and gout presented in June 2021 with bilateral red eyes following Coronavirus disease (COVID-19) vaccination.
J Am Soc Nephrol
January 2025
Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030.
Background: Arteriovenous (AV) fistulas are the preferred access for dialysis but have a high incidence of failure. This study aims to understand the crosstalk between skeletal muscle catabolism and AV fistula maturation failure.
Methods: Skeletal muscle metabolism and AV fistula maturation were evaluated in mice with chronic kidney disease (CKD).
Stroke
January 2025
Department of Neurology, Medical College of Georgia, Augusta University. (M.B.K., B.B., D.C.H.).
Background: Remote ischemic conditioning (RIC) is a simple and low-cost intervention that is thought to increase collateral blood flow through the vasodilatory effects of nitric oxide (NO) produced by the endothelium and red blood cells (RBCs). This study aims to investigate whether RIC affects RBC deformability and levels of NO and nitrite in patients with ischemic stroke.
Methods: This is a predefined substudy to the RESIST (Remote Ischemic Conditioning in Patients With Acute Stroke Trial) randomized clinical trial conducted in Denmark.
Kidney Med
February 2025
Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pure red cell aplasia (PRCA) is a rare complication of erythropoietin (EPO) therapy, characterized by a severe deficiency in red blood cell production. There is no guideline on the treatment for PRCA because there have been too few cases to perform prospective cohort studies. The main treatments for PRCA include immediate cessation of EPO, restrictive transfusion, and immunosuppressive therapies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!